<?xml version="1.0" encoding="UTF-8"?>
<p>The growing number of pharmacies has resulted in a systematic drop in profitability. Profit-oriented entrepreneurs began to look for other sources of income besides their retail margin. This resulted in the creation of an inverted distribution chain that causes problems leading to a lack of availability of many drugs for Polish patients. “Reverse distribution chain” is the sale of drugs in a direction contrary to the supply chain assumptions, i.e., not to patients, but rather to entities that export them abroad for higher profits. Reacting to the illegal export of drugs, manufacturers then limit the amount of supplies or limit them to selected, preferred recipients, which increases the problems with purchasing drugs. Drugs are exported and sold abroad due to the difference in prices between Poland and other European Union countries because drug prices in Poland are among the lowest in Europe [
 <xref rid="B15-ijerph-17-08751" ref-type="bibr">15</xref>,
 <xref rid="B16-ijerph-17-08751" ref-type="bibr">16</xref>,
 <xref rid="B17-ijerph-17-08751" ref-type="bibr">17</xref>]. The announcement of the Minister of Health indicated that the list of drugs at risk of availability in June 2020 included 298 drugs (according to EAN codes).
</p>
